SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-307293
Filing Date
2019-12-05
Accepted
2019-12-05 16:10:56
Documents
3
Period of Report
2020-01-15
Effectiveness Date
2019-12-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A d840232ddef14a.htm DEF 14A 462235
2 GRAPHIC g840232g80y55.jpg GRAPHIC 4801
3 GRAPHIC g840232g97m83.jpg GRAPHIC 16028
  Complete submission text file 0001193125-19-307293.txt   492346
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36783 | Film No.: 191270531
SIC: 2834 Pharmaceutical Preparations